Intervention groups | At 3rd month follow-up | p-value (chi2)* | At 6th month follow-up | p-value (chi2)* | ||
---|---|---|---|---|---|---|
HbA1c < 7% | HbA1c ≥ 7% | HbA1c < 7% | HbA1c ≥ 7% | |||
Per-Protocol (PP) analysis | ||||||
DT + OHI | 0 (0) | 24 (100) | 0.020 (7.78) | 2 (8.33) | 22 (91.67) | 0.061 (5.60) |
SRP + OHI | 5 (19.23) | 21 (80.77) | 9 (34.62) | 17 (65.38) | ||
SRP + MET + OHI | 7 (29.17) | 17 (70.83) | 8 (33.33) | 16 (66.67) | ||
Intention-To-Treat (ITT) analysis | ||||||
DT + OHI | 1 (3.13) | 31 (96.88) | 0.045 (6.22) | 2 (8.33) | 22 (91.67) | 0.061 (5.60) |
SRP + OHI | 5 (15.15) | 28 (84.85) | 9 (34.62) | 17 (65.38) | ||
SRP + MET + OHI | 8 (25.0) | 24 (75.0) | 8 (33.33) | 16 (66.67) |